Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors
Titel:
Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors
Auteur:
Koda, Robert T. Garcia, Agustin A. Chatterjee, Dhruba J. Li, Wen Yen Parimoo, Deepika Jeffers, Susan Rogers, Marion Leichman, C. Gail Leichman, Lawrence Wu, Ellen Y. Shetty, Bhasker V. Webber, Stephanie Clendinnin, Neil Muggia, Franco M.